Cabot Corporation ( CBT Quick Quote CBT - Free Report) recently announced the launch of a new Engineered Elastomer Composites (E2C) product for use in industrial rubber products. The latest product E2C DZ8650 forms part of the Durability series of solutions, which intends to lower in-field failures and maximize operational uptime.
The purpose of DZ8650 is not only to deliver breakthrough improvements in erosion and wet abrasion resistance, but also provide mechanical strength in mining rubber applications including slurry pumps, hydro cyclones and rubber pipes.
The product DZ8650 can be combined in the current production process of industrial rubber manufacturer without any additional capital spending. This will facilitate producers to reform their business model by improving performance, shortening development cycles and lower operational barriers to new product commercialization.
E2C family of solutions, which was launched in early 2020, has an addition in the form of DZ8650. This reflects on Cabot’s commitment to help tire and rubber products manufacturers reach performance goals as well as improve sustainability.
Shares of Cabot have gained 86.8% in the past year compared with 93.2% rise of the
Cabot, in its last earnings call, stated that it expects near-term conditions to remain favorable while long term visibility is limited. It forecasts strength in demand in the second quarter. It anticipated an increase in raw material and fixed costs sequentially and less customer inventory replenishment compared to the first quarter.
On the basis of these factors, adjusted earnings per share are projected in the range of 90 cents to $1.00. The company expects that the pandemic resurgence or related factors will not have a significant disruption impact on the ongoing business environment.
Zacks Rank & Other Key Picks
Cabot currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the basic materials space are
Fortescue Metals Group Limited ( FSUGY Quick Quote FSUGY - Free Report) , BHP Group ( BHP Quick Quote BHP - Free Report) and Impala Platinum Holdings Limited ( IMPUY Quick Quote IMPUY - Free Report) .
Fortescue has a projected earnings growth rate of 107.8% for the current fiscal. The company’s shares have surged around 201.1% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see
the complete list of today’s Zacks #1 Rank stocks here.
BHP has an expected earnings growth rate of 76.8% for the current fiscal. The company’s shares have gained 136% in the past year. It currently sports a Zacks Rank #1.
Impala has an expected earnings growth rate of 186.9% for the current fiscal. The company’s shares have rallied around 252.5% in the past year. It currently sports a Zacks Rank #1.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>